181 related articles for article (PubMed ID: 2463265)
1. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.
Matsubara T; Saura R; Hirohata K; Ziff M
J Clin Invest; 1989 Jan; 83(1):158-67. PubMed ID: 2463265
[TBL] [Abstract][Full Text] [Related]
2. Copper chelation by D-penicillamine generates reactive oxygen species that are cytotoxic to human leukemia and breast cancer cells.
Gupte A; Mumper RJ
Free Radic Biol Med; 2007 Nov; 43(9):1271-8. PubMed ID: 17893040
[TBL] [Abstract][Full Text] [Related]
3. Bucillamine inhibits T cell adhesion to human endothelial cells.
Eguchi K; Kawakami A; Ida H; Nakashima M; Yamashita I; Sakai M; Shimada H; Terada K; Fukuda T; Ishimaru T
J Rheumatol; 1992 Jul; 19(7):1045-50. PubMed ID: 1512757
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes.
Lipsky PE
J Clin Invest; 1984 Jan; 73(1):53-65. PubMed ID: 6606652
[TBL] [Abstract][Full Text] [Related]
5. The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts.
Lipsky PE; Ziff M
J Immunol; 1978 Mar; 120(3):1006-13. PubMed ID: 632576
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human endothelial cell proliferation by gold compounds.
Matsubara T; Ziff M
J Clin Invest; 1987 May; 79(5):1440-6. PubMed ID: 3106416
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4.
Lipsky PE; Ziff M
J Clin Invest; 1980 May; 65(5):1069-76. PubMed ID: 6965944
[TBL] [Abstract][Full Text] [Related]
8. Suppression of human fibroblast proliferation by D-penicillamine and copper sulfate in vitro.
Matsubara T; Hirohata K
Arthritis Rheum; 1988 Aug; 31(8):964-72. PubMed ID: 3261590
[TBL] [Abstract][Full Text] [Related]
9. An investigation into copper catalyzed D-penicillamine oxidation and subsequent hydrogen peroxide generation.
Gupte A; Mumper RJ
J Inorg Biochem; 2007 Apr; 101(4):594-602. PubMed ID: 17275091
[TBL] [Abstract][Full Text] [Related]
10. Suggested mode of action of D-penicillamine as an immunosuppressive agent in rheumatoid arthritis.
Lipsky PE
Z Rheumatol; 1988; 47 Suppl 1():6-8. PubMed ID: 2975107
[TBL] [Abstract][Full Text] [Related]
11. D-Penicillamine: analysis of the mechanism of copper-catalyzed hydrogen peroxide generation.
Starkebaum G; Root RK
J Immunol; 1985 May; 134(5):3371-8. PubMed ID: 2984288
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo interactions of D-penicillamine with tumors.
Samoszuk M; Nguyen V
Anticancer Res; 1996; 16(3A):1219-23. PubMed ID: 8702240
[TBL] [Abstract][Full Text] [Related]
13. Use of a monoclonal antibody specific for activated endothelial cells to quantitate angiogenesis in vivo in zebrafish after drug treatment.
Seng WL; Eng K; Lee J; McGrath P
Angiogenesis; 2004; 7(3):243-53. PubMed ID: 15609079
[TBL] [Abstract][Full Text] [Related]
14. Enhanced intracellular delivery of the reactive oxygen species (ROS)-generating copper chelator D-penicillamine via a novel gelatin--D-penicillamine conjugate.
Gupte A; Wadhwa S; Mumper RJ
Bioconjug Chem; 2008 Jul; 19(7):1382-8. PubMed ID: 18570451
[TBL] [Abstract][Full Text] [Related]
15. Differences in the effects of the antirheumatic drugs, bucillamine and D-penicillamine, on mitogen-induced proliferation of mouse spleen cells.
Mita S; Matsunaga K
Agents Actions; 1990 Jun; 30(3-4):363-8. PubMed ID: 2386109
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate.
Hirata S; Matsubara T; Saura R; Tateishi H; Hirohata K
Arthritis Rheum; 1989 Sep; 32(9):1065-73. PubMed ID: 2476134
[TBL] [Abstract][Full Text] [Related]
17. A mechanism of action of gold sodium thiomalate in diseases characterized by a proliferative synovitis: reversible changes in collagen production in cultured human synovial cells.
Goldberg RL; Parrott DP; Kaplan SR; Fuller GC
J Pharmacol Exp Ther; 1981 Aug; 218(2):395-403. PubMed ID: 6788936
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo inhibition of activation induced T cell apoptosis by bucillamine.
Okazaki H; Sato H; Kamimura T; Hirata D; Iwamoto M; Yoshio T; Mimori A; Masuyama JI; Kano S; Minota S
J Rheumatol; 2000 Jun; 27(6):1358-64. PubMed ID: 10852254
[TBL] [Abstract][Full Text] [Related]
19. A mechanism of cisplatin action: antineoplastic effect through inhibition of neovascularization.
Yoshikawa A; Saura R; Matsubara T; Mizuno K
Kobe J Med Sci; 1997 Aug; 43(3-4):109-20. PubMed ID: 9489296
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of gold and other drugs on mononuclear cell responses: a comparison.
Harth M; Stiller CR
J Rheumatol Suppl; 1979; 5():112-6. PubMed ID: 158654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
